Continuing Education, Industry, and Physicians  by DeMaria, Anthony N.
CI
p
c
a
m
s
C
a
p
t
a
v
p
d
a
f
l
e
c
o
i
p
h
s
d
p
2
c
e
s
o
a
t
Journal of the American College of Cardiology Vol. 52, No. 12, 2008
© 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00
Published by Elsevier Inc. doi:10.1016/j.jacc.2008.08.015EDITOR’S PAGEontinuing Education, Industry, and PhysiciansAnthony N. DeMaria,
MD, MACC
Editor-in-Chief,
Journal of the American
College of Cardiology
I think physicians
are intelligent,
savvy, and inde-
pendent enough to
know bias when
they see it, and to
resist recommenda-
tions that are not
based on firm data.n no other profession is lifelong continuing education as valued and pursued as in
medicine. Our profession is one in which the fund of knowledge is constantly in-
creasing. We physicians pride ourselves on keeping abreast of new information and
roviding patients with the best possible treatment.
The traditional vehicle for staying current has been certified continuing medical edu-
ation (CME). On any given day, scores of conferences are conducted on virtually every
spect of cardiovascular medicine. Acquiring the latest knowledge requires both time and
oney. Over the years, the pharmaceutical and device industries have become major
upporters of CME and have offset the cost to the profession. Obviously, supporting
ME has not been entirely altruistic. The industry clearly hoped to benefit not only by
n informed profession, but also by the opportunity to deliver a message about their
roducts. Now that support may be coming to an end, the American Medical Associa-
ion (AMA) and Accreditation Council for Continuing Medicine Education (ACCME)
re considering proposals to eliminate all commercial support for certified CME. I have
ery mixed feelings about such an action.
When I began my career, some 3 decades ago, the interaction between industry and
hysicians was primarily promotional and solicitous. Often this interaction had little to
o with clinical practice or even the commercial product. I was taken to sporting events
nd hosted on the golf course by industry. Lavish receptions were held with expensive
ood, open bars, and the opportunity to meet celebrities like the Dallas Cowboy Cheer-
eaders. It was not always obvious how such activities increased medical knowledge or
nhanced clinical care.
It was in this setting that the concept evolved that supporting medical education
ould elevate the level of practice and benefit industry at the same time. The importance
f medical education was reinforced by the requirement for CME credits for many med-
cal privileges. Soon commercial interests became major supporters of CME. This sup-
ort has been estimated to amount to nearly $1 billion per year and has enabled us to
ave the breadth and depth of learning opportunities we currently enjoy.
From the beginning, it was recognized that the educational goals of conferences
hould not be unduly influenced by commercial interests. The AMA and ACCME cre-
entialed providers of CME. Over the years, guidelines separating industry from the
rocess of determining the need for and the content of CME were strengthened. In
002, the Pharmaceutical Research and Manufacturers of America published their own
ode defining appropriate interaction of industry with health care professionals. In gen-
ral, the guidelines consisted of entrusting the responsibility for program content and
peakers to the agency granting CME, and full disclosure of relationships with industry
n the part of presenters.
Most will agree that the separation between the composition of educational programs
nd commercial interests has not always been perfect. Perhaps it shouldn’t be. It seems
o me unreasonable to think that a company that produces angioplasty catheters would
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Editor’s Page September 16, 2008:1035–6e interested in sponsoring a program on obstetrics. As
ointed out in a statement from the Council of Medical
pecialty Societies, the Gerber Foundation, dedicated to
dvance the quality of life in infants and young children,
ould not likely be interested in supporting programs on
lzheimer’s Disease. However, whether the result of con-
cious or subconscious actions, program content has
ometimes appeared to primarily serve the interest of its
upporters.
As stated above, the potential influence of industry in
ME has received increasing attention from accrediting
gencies, specialty societies, and academic institutions.
owever, likely stimulated by the increasing cost of
ealth care, scrutiny reached a new level when the Senate
inance Committee and the Office of the Inspector Gen-
ral of the Department of Health and Human Services
ecame involved. Both groups are concerned with the
otential of commercial entities to exert undue influence
pon physicians which results in increasing health care
osts. The effects that this scrutiny had upon others can-
ot be certain. However, whether a coincidence or not,
ecently both the AMA and ACCME have developed
raft documents that propose alternatives for the role of
ndustry in CME, including the elimination of all com-
ercial support for CME activities. Needless to say, the
ffect of such an action upon medical societies, physicians,
nd perhaps even journals, could be substantial.
My first reaction upon learning of these proposals was
o agree with their underlying principle. I think it is criti-
al to distinguish between certified CME and promo-
ional events. The need for, content of, and presenters for
 CME activity should be determined solely based upon
ducational objectives. The Program Directors should be
esponsible for these decisions. Events that deal with the
se of specific drugs or devices should be clearly desig-
ated as promotional and adhere to Food and Drug Ad-
inistration requirements. A physician attending a certi-
ed CME event should feel confident that the material
resented represents the objective opinion of the faculty,
ree of commercial influence.
That having been said, I worry that termination of all
ommercial support is a major overreaction. The goal that
nderlies eliminating commercial funding—that is, to in-
ure program objectivity— can be accomplished by exist-
ng CME-granting agencies. Certainly medical societies
nd academic institutions should be capable of excluding
nappropriate industry impact. In addition, is not clear Eow or if the financial support for CME provided by in-
ustry could be replaced. Without these funds, important
pportunities to increase knowledge might be unavailable
o busy clinicians, thereby denying their patients the ben-
fits of this learning. It is not known what industry would
o with the money they are currently directing to CME.
owever, it would likely go to more promotional events
nd/or direct-to-consumer advertising, neither of which
ddresses the concerns that have been raised. In fact, such
lternate venues would probably only serve to further in-
rease the use of products.
I have a further, even more basic, reservation about the
roposal to end commercial support for CME. Inherent
n such an action is the idea that physicians are like
heep: easily led and without the ability to recognize bi-
sed or slanted information. I find this demeaning to the
rofession. In my experience, physicians are more skepti-
al than naïve; by nature they are not anxious to accept,
ut rather are waiting to be convinced. Given the com-
etitive demands entailed in becoming a physician, we are
ikely intelligent enough to recognize bias when it is
resent.
So, I view the proposal to eliminate all industrial sup-
ort of medical education as throwing the baby out with
he bath water. I agree that certified CME should be ob-
ective and free of all bias, and I am not naïve enough to
hink that this has been fully achieved. However, I think
here are other ways to accomplish this goal, and that
e have the structure in place to be successful in the
CCME, medical societies, and academic institutions.
ightening existing guidelines and greater diligence to
dherence should be adequate. Equally important, I think
hysicians are intelligent, savvy, and independent enough
o know bias when they see it, and to resist recommenda-
ions that are not based on firm data. Physicians may not
e perfect, but in pursuing continuing education, we have
et an example for other professions to follow. Industrial
upport has helped to make this possible; let’s think long
nd hard before we upset the cart.
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